Group 1 - The core point of the news is that Green Leaf Pharmaceutical has received formal acceptance from the National Medical Products Administration of China for the new indication application of its innovative drug, Ruoxinlin®, for the treatment of generalized anxiety disorder, marking a significant milestone since its approval for depression treatment in November 2022 [1] - Ruoxinlin® is expected to be the first SNDRI (serotonin, norepinephrine, and dopamine reuptake inhibitor) in China for treating generalized anxiety disorder, potentially benefiting a larger patient population [1] - The new indication application is based on a Phase III clinical study involving 555 patients, demonstrating that Ruoxinlin® can rapidly and comprehensively improve anxiety symptoms, with an efficacy rate exceeding 80% and a relief rate of approximately 50% [1] Group 2 - Anxiety disorders are the most common mental disorders in China, with approximately 58.67 million people affected, and generalized anxiety disorder has a lifetime prevalence rate of about 4.1%-6.6% among adults [2] - Current first-line treatments for generalized anxiety disorder, SSRIs and SNRIs, have limited efficacy, with a meta-analysis showing an overall efficacy rate of 67.7% and a relief rate of only 39.7% [2] - The market size for SSRIs and SNRIs is projected to be 4.83 billion yuan in 2024, with no innovative drugs approved in the last 20 years, highlighting a significant gap in the supply of innovative anti-anxiety treatments in China [2] Group 3 - Ruoxinlin® has served nearly 190,000 patients since its approval, gaining widespread recognition for its efficacy and safety, and is one of the fastest-growing antidepressants in China [3] - The drug is expected to be included in the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog by the end of 2024, further enhancing its accessibility [3] - The company has a long-term strategic focus on the central nervous system treatment field, with a diverse product portfolio that includes treatments for schizophrenia, bipolar disorder, and Alzheimer's disease, alongside ongoing development of next-generation innovative drugs [4]

Core Insights - The research from Harvard University reveals a dual mechanism by which stress leads to hair loss, providing new insights into autoimmune diseases [1] Group 1: Mechanism of Hair Loss - The first mechanism identified is "immediate hair loss," triggered by the sympathetic nervous system's response to stress, resulting in the release of high levels of norepinephrine, which can kill rapidly proliferating cells in hair follicles [1] - The second mechanism involves the destruction of hair follicles by norepinephrine, which leads the body to perceive the damaged tissue as foreign, triggering an immune response that activates CD8+ T cells to attack hair follicles, potentially causing recurrent hair loss with lasting effects [1] Group 2: Implications for Autoimmune Diseases - This discovery is significant for understanding autoimmune diseases, as conditions like type 1 diabetes, lupus, and multiple sclerosis often require external triggers, with stress potentially being one of them [1]

Core Insights - A new study from MIT provides scientific evidence that lack of sleep can impair attention due to a physiological mechanism where cerebrospinal fluid (CSF) is involved in "cleaning" the brain during sleep, which is disrupted when sleep is insufficient [2][18] Group 1: Research Findings - The study reveals that during moments of attention lapses, a wave of cerebrospinal fluid flows out of the brain, a process typically occurring during sleep to clear waste accumulated during the day [2][18] - Insufficient sleep leads to the activation of this cleaning process during waking hours, resulting in significant attention deficits [18][21] - The research involved 26 healthy volunteers who underwent attention tests under both sufficient and insufficient sleep conditions, showing that sleep-deprived individuals had longer reaction times and sometimes failed to respond altogether [19][21] Group 2: Mechanism of Action - The study indicates that during deep sleep, a synchronized activity of neurons allows for a significant withdrawal of blood, creating space for cerebrospinal fluid to enter and cleanse the brain [15][26] - In contrast, when awake, the active state of neurons prevents this cleaning process, leading to a buildup of waste and forcing the brain to initiate a similar cleaning mechanism while awake, which detracts from attention resources [26][27] - The research suggests that there may be a central switch in the brain that regulates attention and the flow of cerebrospinal fluid, potentially influenced by norepinephrine [29]

Core Viewpoint - The article highlights the significant contributions of Professor Danyang in the field of sleep research and her recent affiliation with Shenzhen Medical Academy, where she will establish a Sleep and Consciousness Laboratory [1][4]. Group 1: Professor Danyang's Background - Professor Danyang graduated from Peking University with a degree in Physics and later pursued a PhD in Biology at Columbia University, followed by postdoctoral research at Rockefeller University and Harvard Medical School [4]. - She has been a faculty member at the University of California, Berkeley since 1997, focusing on the neural circuits that control sleep and the functions of the prefrontal cortex [4][21]. Group 2: Recent Research Contributions - On December 8, 2023, Professor Danyang's team published a study in Cell, revealing that frontal cortical ignition, related to consciousness awareness, is strongly suppressed during NREM sleep in mice due to cholinergic modulation [7][10]. - On January 18, 2024, a study published in Nature Neuroscience demonstrated that microglia can promote sleep through calcium-dependent modulation of norepinephrine transmission, suggesting a protective role for microglia in brain health [12][13]. - On January 17, 2025, a study in Science Advances explored how activation of locus coeruleus noradrenergic neurons rapidly increases homeostatic sleep pressure, indicating a mechanism for sleep regulation [15][17]. Group 3: Implications for Sleep Research - The findings from Professor Danyang's research suggest that understanding the mechanisms of sleep regulation could have implications for addressing sleep disruptions associated with neurodegenerative diseases like Alzheimer's [13]. - The research emphasizes the importance of microglial function in maintaining sleep and brain homeostasis, potentially offering insights into therapeutic strategies for sleep-related disorders [13]. - The studies collectively indicate that the functional fatigue of locus coeruleus neurons may lead to increased sleep pressure, providing a new perspective on the relationship between wakefulness and sleep [17].